Tendee LogoChatBlog
Public Tender Opportunity

Portugal – Immune sera and immunoglobulins – 2024/0963 - NIRSEVIMAB [50 MG/0.5 ML SOL INJ SERINGA]

Published on October 21, 2025

Tender Description

NIRSEVIMAB [50 MG/0.5 ML SOL INJ SERINGA]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.

Portugal – Immune sera and immunoglobulins – 2024/0963 - NIRSEVIMAB [50 MG/0.5 ML SOL INJ SERINGA] | Public Tender | tend.ee